Publikationen (92) Publikationen von María José García Velloso

2024

  1. Continuous innovation in precision radio-guided surgery

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 43, Núm. 1, pp. 39-54

2023

  1. Disseminated lymphadenopathy during chemotherapy for squamous cell lung carcinoma

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 438-440

  2. FDG-PET/CT and new radiopharmaceuticals in patients with multiple myeloma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 2, pp. 129-135

  3. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

  4. SEMNIM has a plan and is counting on you

    Revista Espanola de Medicina Nuclear e Imagen Molecular

  5. Syphilis Mimicking Malignant Pulmonary Tumor With Nodal and Bone Metastasis on 18 F-FDG PET/CT

    Clinical nuclear medicine, Vol. 48, Núm. 11, pp. e526-e528

2022

  1. 11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value

    International Journal of Molecular Sciences, Vol. 23, Núm. 17

  2. Pancreatic involvement in a patient with multiple myeloma revealed by [18F]FDG PET/CT. A rare manifestation of extramedullary disease

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, pp. S48-S50

2021

  1. A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment

    Clinical and Translational Oncology, Vol. 23, Núm. 3, pp. 434-449

  2. Diagnostic accuracy of visual analysis versus dual time-point imaging with 18F-FDG PET/CT for the characterization of indeterminate pulmonary nodules with low uptake

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 3, pp. 155-160

  3. Early imaging and molecular changes with neoadjuvant bevacizumab in stage ii/iii breast cancer

    Cancers, Vol. 13, Núm. 14

  4. Immunotherapy, cancer and PET

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 2, pp. 123-135

  5. Pulmonary Artery Sarcoma with Low 18F-FDG Uptake

    Clinical Nuclear Medicine, Vol. 46, Núm. 2, pp. e127-e128

  6. Ultra-low dose whole-body CT for attenuation correction in a dual tracer PET/CT protocol for multiple myeloma

    Physica Medica, Vol. 84, pp. 1-9

2020

  1. Article18 f-fdg and11 c-methionine pet/ct in newly diagnosed multiple myeloma patients: Comparison of volume-based pet biomarkers

    Cancers, Vol. 12, Núm. 4

  2. Elevated circulating metalloproteinase 7 predicts recurrent cardiovascular events in patients with carotid stenosis: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 20, Núm. 1

  3. FDG PET/CT in colorectal cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 1, pp. 57-66

  4. The utility of ADC value in diffusion-weighted whole-body MRI in the follow-up of patients with multiple myeloma. Correlation study with 18F-FDG PET-CT

    European Journal of Radiology, Vol. 133

2019

  1. 18F-FDG PET/CT in locally advanced cervical cancer: A review

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 38, Núm. 1, pp. 59-68

2018

  1. 68Ga-PSMA PET/CT in prostate cancer

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 2, pp. 130-138